Non-interventional post-authorization safety study of filgotinib in the treatment of patients with moderate to severe active rheumatoid arthritis within European registries

First published 12/07/2022

Last updated 05/09/2024

EU PAS number:

EUPAS46856

Study

Ongoing

Documents

Study protocol

Initial protocol

glpg0634-cl-403-protocol-redacted

English (7.2 MB - PDF)View document

Updated protocol

glpg0634-cl-403-protocol V2_Redacted.pdf

First published: 23/04/2024

English (8.43 MB - PDF)View document

Study results

Study report

Other information

Secondary tabs